☆ 3.9 Meeting Abstract

Quality of life effects of intermittent and continuous hormonal therapy by cyproterone acetate (CPA) for metastatic prostate cancer

EUROPEAN UROLOGY SUPPLEMENTS (2008)

Get Full Text
Add to Collection

Journal

EUROPEAN UROLOGY SUPPLEMENTS
Volume 7, Issue 3, Pages 206-206

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S1569-9056(08)60537-0

Keywords

-

Categories

Urology & Nephrology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.